Dexcom (DXCM) Other financing activities (2018 - 2026)
Dexcom (DXCM) posted quarterly Other financing activities of -$1.9 million for Q2 2026, down 11.76% year-over-year from -$2.2 million in Q2 2025, and little changed quarter-over-quarter from -$1.9 million in Q1 2026.
Dexcom (DXCM) Other financing activities (2018 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Other financing activities for 9 consecutive years, with -$1.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other financing activities fell 11.76% year-over-year to -$1.9 million; the TTM figure through Jun 2026 stood at -$7.4 million (down 17.46% YoY), while the FY2025 annual figure was -$7.0 million, up 46.15% from the prior year.
- Other financing activities steadied at -$1.9 million in Q2 2026 per DXCM's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Other financing activities topped out at $4.9 million in Q4 2023 and bottomed at -$8.7 million in Q1 2024.
- Historically, Other financing activities has averaged -$2.2 million across 5 years, with a median of -$1.7 million in 2025.
- Annual changes were most pronounced in 2022 — Other financing activities plunged 975.0% — and 2023, when it jumped 590.0%.
- Dexcom's Other financing activities stood at -$1.0 million in 2022, then surged by 590.0% to $4.9 million in 2023, then tumbled by 132.65% to -$1.6 million in 2024, then fell by 18.75% to -$1.9 million in 2025, then changed by 0.0% to -$1.9 million in 2026.
- Business Quant data shows DXCM's Other financing activities at -$1.9 million in Q2 2026, -$1.9 million in Q1 2026, and -$1.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.90 Mn |
| Jun 30, 2026 | -1.90 Mn |
| Mar 31, 2026 | -1.90 Mn |
| Mar 31, 2026 | -1.90 Mn |
| Dec 31, 2025 | -1.90 Mn |
| Dec 31, 2025 | -1.90 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | -1.70 Mn |
| Mar 31, 2025 | -1.70 Mn |
| Dec 31, 2024 | -1.60 Mn |
| Dec 31, 2024 | -1.60 Mn |
| Sep 30, 2024 | -1.30 Mn |
| Sep 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -8.70 Mn |
| Mar 31, 2024 | -8.70 Mn |